SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

Board Change

2 Nov 2020 07:00

RNS Number : 8512D
Bowleven plc
02 November 2020
 

 

 

 

 

 

2 November 2020

 

Bowleven plc

('Bowleven' or 'the Group' or 'the Company')

 

Board Change

 

Bowleven plc is pleased to announce the appointment of Jack Arnoff to the Board of the Company as a Non-Executive Director with immediate effect.

 

Jack has a wealth of knowledge and experience in investment and asset management. He has played a key role in product development and marketing of emerging markets products. He currently holds the position of co-founder and Partner at Elbrus Capital Partners LLP and Portfolio Manager for ECP Emerging Europe Value Fund. Jack has an intimate understanding of the sector and key relationships with relevant institutions that will bode well for supporting Bowleven as it seeks both project financing and Final Investment Decision on Etinde.

 

Commenting on the appointment, Bowleven's CEO, Eli Chahin, said:

 

"We are pleased to welcome Jack to the Board. Jack brings a wealth of experience and has extensive relationships in the global energy sector and with capital providers. As a member of the Board, Jack will bring a unique set of experiences, diverse perspective and guidance to help drive the Company towards its strategic Etinde growth plan."

 

Additional information:

 

Name

Jack Arnoff

 

Age

54

 

Current Directorships / Partnerships

Elbrus Capital Partners LLP

 

Elbrus Capital (Cayman) Ltd

Former Directorships / Partnerships (in last 5 years)

ECP Emerging Europe Value Fund Ltd (Cayman)

 

 

Save for the above, there is no further information that is required to be disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies with respect to the appointment.

 

ENQUIRIES

For further information, please contact:

 

Bowleven plc

Eli Chahin, Chief Executive

00 44 20 3327 0150

Celicourt Communications Ltd

Mark Antelme

00 44 20 8434 2643

Jimmy Lea

Shore Capital (NOMAD and Broker)

Antonio Bossi

Robert Finlay

00 44 207 601 6100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFEALLLLIII
Date   Source Headline
24th Sep 20247:00 amRNSCancellation - BowLeven Plc
20th Sep 20247:00 amRNSHolding(s) in Company
17th Sep 20246:00 pmRNSBowLeven
12th Sep 202410:11 amRNSResult of Exit Opportunity
28th Aug 20242:25 pmRNSResult of GM
9th Aug 20247:00 amRNSCancellation, Exit Opportunity & Notice of GM
22nd Jul 20247:00 amRNSBoard Appointment
30th May 20241:46 pmRNSBlock Admission Update
9th May 20249:52 amRNSBlock Admission Six Monthly Return
9th Apr 20243:43 pmRNSHolding(s) in Company
3rd Apr 202410:35 amRNSResults of Open Offer
2nd Apr 20241:43 pmRNSResult of General Meeting
27th Mar 20247:00 amRNSInterim Results
18th Mar 20247:54 amRNSHolding(s) in Company
15th Mar 20247:00 amRNSStandard form for notification of major holdings
14th Mar 20247:00 amRNSProposed Underwritten Open Offer to raise c$2m
12th Mar 20243:49 pmRNSHolding(s) in Company
25th Jan 202410:59 amRNSTermination of Transaction
6th Dec 20233:43 pmRNSRESULT OF ANNUAL GENERAL MEETING
15th Nov 20235:47 pmRNSPosting of Annual Report and Accounts 2023
10th Nov 20237:00 amRNSFull Year Results
9th Nov 20237:00 amRNSBlock Admission Six Monthly Return
26th Sep 20237:00 amRNSCorporate Update
21st Jul 20237:00 amRNSResponse to Share Price Movement
9th May 20237:00 amRNSBlock Admission Six Monthly Return
30th Mar 20237:00 amRNSInterim Results
25th Jan 202311:00 amRNSPrice Monitoring Extension
25th Jan 20239:05 amRNSSecond Price Monitoring Extn
25th Jan 20239:00 amRNSPrice Monitoring Extension
1st Dec 202211:48 amRNSRESULT OF ANNUAL GENERAL MEETING
9th Nov 20227:00 amRNSBlock Admission Six Monthly Return
7th Nov 20227:00 amRNSPosting of Annual Report and Accounts 2022
1st Nov 20224:41 pmRNSSecond Price Monitoring Extn
1st Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20227:30 amRNSFull Year Results
18th Aug 20224:41 pmRNSSecond Price Monitoring Extn
18th Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 202211:05 amRNSSecond Price Monitoring Extn
18th Aug 202211:00 amRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSChange of Partner and Operator at Etinde Licence
13th Jun 20222:05 pmRNSSecond Price Monitoring Extn
13th Jun 20222:00 pmRNSPrice Monitoring Extension
7th Jun 202211:00 amRNSPrice Monitoring Extension
7th Jun 20227:00 amRNSChange of Partner and Operator at Etinde Licence
23rd May 20222:05 pmRNSSecond Price Monitoring Extn
23rd May 20222:00 pmRNSPrice Monitoring Extension
9th May 20228:32 amRNSBlock Admission Six Monthly Review
30th Mar 20227:00 amRNSInterim Results
13th Dec 20212:06 pmRNSSecond Price Monitoring Extn
13th Dec 20212:01 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.